WallStreetZenWallStreetZen

NASDAQ: EKSO
Ekso Bionics Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EKSO

Based on 1 analyst offering 12 month price targets for Ekso Bionics Holdings Inc

Min Forecast
$6.00-35.9%
Avg Forecast
$6.00-35.9%
Max Forecast
$6.00-35.9%

Should I buy or sell EKSO stock?

Based on 1 analyst offering ratings for Ekso Bionics Holdings Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although EKSO's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates EKSO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their EKSO stock forecasts and price targets.

EKSO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-18

1 of 1

Forecast return on equity

Is EKSO forecast to generate an efficient return?

Company
33.17%
Industry
25.24%
Market
218.22%
EKSO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EKSO forecast to generate an efficient return on assets?

Company
14.82%
Industry
18.52%
EKSO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EKSO earnings per share forecast

What is EKSO's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.42
Avg 2 year Forecast
-$0.06
Avg 3 year Forecast
-$0.15

EKSO revenue forecast

What is EKSO's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$23.2M+57.27%
Avg 2 year Forecast
$24.9M+68.74%
EKSO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EKSO revenue growth forecast

How is EKSO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
21.69%
Industry
9.85%
Market
22.77%
EKSO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EKSO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EKSO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
EKSO$9.36$6.00-35.90%Buy
ZJYL$0.14N/AN/A
HBIO$0.47$2.00+323.73%Buy
FEMY$0.49$7.25+1,394.85%Strong Buy
MLSS$0.26$1.00+292.16%Buy
View Top Medical Stocks

Ekso Bionics Holdings Stock Forecast FAQ

Is Ekso Bionics Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EKSO) stock is to Buy EKSO stock.

Out of 1 analyst, 0 (0%) are recommending EKSO as a Strong Buy, 1 (100%) are recommending EKSO as a Buy, 0 (0%) are recommending EKSO as a Hold, 0 (0%) are recommending EKSO as a Sell, and 0 (0%) are recommending EKSO as a Strong Sell.

If you're new to stock investing, here's how to buy Ekso Bionics Holdings stock.

What is EKSO's earnings growth forecast for 2026-2028?

(NASDAQ: EKSO) Ekso Bionics Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 32.49%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.01%.

Ekso Bionics Holdings's earnings in 2026 is -$10,434,000.On average, 4 Wall Street analysts forecast EKSO's earnings for 2026 to be -$1,097,036, with the lowest EKSO earnings forecast at -$1,850,953, and the highest EKSO earnings forecast at -$275,439. On average, 3 Wall Street analysts forecast EKSO's earnings for 2027 to be -$160,542, with the lowest EKSO earnings forecast at -$154,246, and the highest EKSO earnings forecast at -$165,264.

In 2028, EKSO is forecast to generate -$401,355 in earnings, with the lowest earnings forecast at -$385,615 and the highest earnings forecast at -$413,159.

What is EKSO's revenue growth forecast for 2026-2027?

(NASDAQ: EKSO) Ekso Bionics Holdings's forecast annual revenue growth rate of 21.69% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.77%.

Ekso Bionics Holdings's revenue in 2026 is $14,749,000.On average, 4 Wall Street analysts forecast EKSO's revenue for 2026 to be $60,848,513, with the lowest EKSO revenue forecast at $49,828,311, and the highest EKSO revenue forecast at $71,889,700.

In 2027, EKSO is forecast to generate $65,287,023 in revenue, with the lowest revenue forecast at $62,726,747 and the highest revenue forecast at $67,207,229.

What is EKSO's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: EKSO) forecast ROA is 14.82%, which is lower than the forecast US Medical Instruments & Supplies industry average of 18.52%.

What is EKSO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EKSO price target, the average EKSO price target is $6.00, with the highest EKSO stock price forecast at $6.00 and the lowest EKSO stock price forecast at $6.00.

The Wall Street analyst predicted that Ekso Bionics Holdings's share price could fall to $6.00 by Nov 18, 2026. The average Ekso Bionics Holdings stock price prediction forecasts a potential downside of 35.9% from the current EKSO share price of $9.36.

What is EKSO's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: EKSO) Ekso Bionics Holdings's current Earnings Per Share (EPS) is -$5.68. On average, analysts forecast that EKSO's EPS will be -$0.42 for 2026, with the lowest EPS forecast at -$0.71, and the highest EPS forecast at -$0.11. On average, analysts forecast that EKSO's EPS will be -$0.06 for 2027, with the lowest EPS forecast at -$0.06, and the highest EPS forecast at -$0.06. In 2028, EKSO's EPS is forecast to hit -$0.15 (min: -$0.15, max: -$0.16).

What is EKSO's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: EKSO) forecast ROE is 33.17%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.